The EVT Viral Genomics and Sequencing Lab at LSU Health Shreveport is first in the state to sequence and report that a new variant of SARS-CoV-2, the virus that causes COVID-19, has been detected in Louisiana. The new variant, B.1.630, was sequenced last week from two samples collected in Baton Rouge.
CENTERS OF EXCELLENCE
A select number of academic programs earn the designation as a Center of Excellence by the Louisiana Board of Regents and must demonstrate statewide leadership in their area of focus and a commitment to building on their respective strengths by advancing knowledge and skills to create better opportunities for improving the quality of life of Louisiana residents. Designated centers share being a hallmark of the institution with a strong performance record, concentration in a clearly defined area relevant to the state’s needs, a range of academic, training and research opportunities, and engagement with the greater community to address current issues. LSU Health Shreveport is home to four designated Centers of Research Excellence.
Feist-Weiller Cancer Center
The Feist-Weiller Cancer Center team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer.
Center of Excellence for Arthritis and Rheumatology
The Center engages in a multidisciplinary clinical, research and education mission to provide patients with cutting-edge care, advance the science of inflammatory and immunology diseases and to educate physicians.
Center for Cardiovascular Diseases and Sciences
The Center's mission is to advance the understanding of cardiovascular disease and translational research while developing future generations of basic and clinical science investigators.
Center for Emerging Viral Threats
The Center intersects critical public health needs with timely delivery of clinical and vaccine trials, testing, key SARS-CoV2 and other pathogen clinical diagnosis, community education, and training scientists, physicians and health work force.
TEACH • HEAL • DISCOVER
Center for Brain Health
The Center for Brain Health expands neuroscience-related education, provides comprehensive care for brain disorders, and attracts young specialists and pioneering clinical trials to North Louisiana, and competes for large scale research funding.
Louisiana Addiction Research Center
LARC is committed to increasing knowledge and advancing research related to Substance Use Disorders to create a better quality of life for the citizens of our area.
Center of Academic Excellence for Patient Centered Rehabilitation
The School of Allied Health Professions' Center (CAE-PaCeR) will establish an infrastructure to bring the relevant academic, research, and clinical programs of the School into alignment for clinical learning, innovation, and collaboration.
Centers of Biomedical Research Excellence
In addition to the six Louisiana Board of Regents and LSU Board of Supervisors approved Centers, LSU Health Shreveport has three National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE). The Centers of Biomedical Research Excellence (COBRE) awards support the establishment and development of innovative, state-of-the-art biomedical and behavioral research centers at institutions in IDeA-eligible states through awards for three sequential five-year phases.
Center for Molecular and Tumor Virology
The Center for Molecular and Tumor Virology, directed by Dr. Martin Sapp, was established in 2002 and has been supported by three consecutive NIH COBRE grants totaling $22.9 million.
Center for Redox Biology and Cardiovascular Disease
The Center for Redox Biology and Cardiovascular Disease, directed by Dr. Chris Kevil, was established in 2018 and is supported by a five-year, $10.5 million NIH COBRE grant.
Center for Applied Immunology and Pathological Processes
The Center for Applied Immunology and Pathological Processes, directed by Dr. Andrew Yurochko, was established In 2021, supported by a five year, $10.5 million grant from the NIH.
Our Centers are actively engaged in educating the community,
training future scientists and advancing research through active collaborations.
LSU Health Shreveport has been on the front line fighting the COVID-19 pandemic since the beginning. The establishment of the Emerging Viral Threats lab in March of 2020 led to mass testing and vaccination sites, clinical trials in patient treatment options and viral sequencing that discovered 7 COVID-19. variants.
A new CDC report finds that U.S. adults reported experiencing increased anxiety and depression symptoms during August through December 2020 as new COVID-19 cases increased. Find strategies to help cope with stress during COVID-19 and how to get help if you’re struggling.
Forum - Dr. Sarwat Umer, Associate Professor of Medicine/Pediatrics, and Dr. Anusha Vuppala, Rheumatology Fellow, at LSUHS share information on Multisystem Inflammatory Syndrome in Children (MIS-C), a complication associated with COVID-19 infection in children.
Red River Radio - In 2020, 5.8 million people were living with Alzheimer’s disease. Dr. Elizabeth Disbrow, Professor of Neurology and Director of Center for Brain Health at LSU Health Shreveport, and Paulette Freeman, Executive Director of The Bridge Alzheimer’s & Dementia Resource Center talk about Alzheimer’s and other forms of dementia and the latest research.
KNOE - Dr. Shawn McNeil, Assistant Professor of Psychiatry and Behavioral Medicine at LSUHS says mental health is as important and in some cases more important than a person’s physical health. He says some children are going through a lot of stressful events right now. including their sleep schedule changing, more expectations in a new grade level, or the pandemic, including mask mandates.
KTAL/KMSS - A summer research program wraps up at LSU Health that’s preparing the next generation of scientists and healthcare professionals. Dr. Karen Stokes, professor of Molecular and Cellular Physiology, said it’s called the CURIOUS program and it's funded by the NIH to bring diversity to health care.
Patch.com - "The CURIOUS program is such a great experience for our students as it allows them to think critically and systematically about science, thus creating new knowledge," said Dr. Scott Chirhart, professor of biology at Centenary. "It's science in action."
The Best of Times - Dr. Elizabeth Disbrow, Professor in Department of Neurology and Director of LSUHS Center for Brain Health, joins Paula Freeman to talk about the resources and education provided by The Bridge, a resource for caregivers and providers of those with Dementia and Alzheimer's.
One recent study found that men fared much worse than women in attention, processing speed, decision-making, memory and language, among others. “We found that men were more cognitively impaired than women across the board,” says Elizabeth Disbrow, Director of the Center for Brain Health at LSU Health Shreveport. “Their cognitive issues were much more pronounced.”
PRNewswire — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world’s leaders on the role of stress in drug addiction.
Louisiana Radio Network - The objective of the grant is to strengthen global capabilities to detect and respond to pandemic threats in the future. Director for Emerging Viral Threats at LSUHS Dr. Andrew Yurochko said the award is indicative of LSU Health Shreveport’s strides in detecting variants and assisting with vaccine rollout.
Red River Radio - Work by Drs. Jeremy Kamil and Rona Scott along with COBRE principal investigators Drs. Andrew Yurochko and Chris Kevil has produced and shared 2,839 full coverage SARS-CoV-2 genomes, which amounts to over 60% of the SARSCoV-2 genome surveillance from Louisiana, and 1.2 % of the total US data submitted to GISAID which is the Global Initiative on Sharing All Influenza Data.
The Rockefeller Foundation - LSU Health Shreveport (LSUHS) is receiving funding ($340,000) from the Rockefeller Foundation. This follows the announcement yesterday of LSUHS being awarded $730,000 to further its work in genomic sequencing of COVID-19 through a NIH supplemental grant. LSUHS joins Harvard and the Broad Institute at MIT among others in the US Regional Accelerators for Genomic Surveillance.
Dr. Arrigo DeBenedetti receives Spring 2021 Feist Weiller Cancer Center (FWCC) Bridging Award grant in the amount of $100,000.